Cancer Marijuana Research Studies

According to a recent survey of over 900 cancer patients, less than 15% received information about medical marijuana from their physician or nurse – despite acknowledgment from the National Cancer Institute that cannabis treats a wide variety of disease symptoms and “has been shown to kill cancer cells.”

Specifically, medical marijuana has demonstrated efficacy in treating the following cancer symptoms and therapy side effects:

• Anxiety
• Depression
• Loss of appetite
• Nausea and vomiting
• Pain and/or nerve damage (neuropathy)

In addition, research suggests cannabis may exert anti-cancer effects by causing cell death, modulating cell-signaling pathways, and inhibiting tumor invasion.

Before purchasing marijuana from a Florida medical marijuana treatment center (MMTC) – or dispensary – patients must first qualify for a medical marijuana certification; CannaMD provides qualified patients with the state-required recommendation to complete this process.

According to Florida state law, patients suffering from cancer may qualify for medical marijuana treatment.

Patients can see if they qualify for free by completing a brief form or calling 1 (855) 420-9170.

For additional information on cancer, please see CannaMD‘s Cancer Patient Resource Page.

CannaMD welcomes the opportunity to connect with fellow physicians and facilitate medical cannabis care.

For additional information, including how to refer cancer patients and request complementary referral cards, please visit CannaMD‘s Physician Resource Page.

While the list below is not exhaustive, we hope you will enjoy the following primary source articles reviewing cancer and marijuana research:

• Antineoplastic activity of cannabinoids
• Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use
• Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy
• Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism
• Cannabinoids: Potential anticancer agents
• Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
• Delta-9 tetrahydrocannabinol inhibits growth and metastasis of lung cancer
• Head and neck cancer among marijuana users
• Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor 
• Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
• NTP toxicology and carcinogenesis studies of 1-trans-delta(9)-tetrahydrocannabinol in F344 rats and B6C3F1 mice
• Marijuana use and cancer incidence (California, United States)
• Marijuana use and the risk of lung and upper aerodigestive tract cancers
• Striking lung cancer response to self-administration of cannabidiol: A case report and literature review
• Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
• The association between marijuana smoking and lung cancer
• The current state and future perspectives of cannabinoids in cancer biology